REMEDIUM LIFECARE
|
REMEDIUM LIFECARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.25 | 15.07 | 2.99 | 1.33 | 0.77 |
| CEPS(Rs) | 0.81 | 0.14 | 0.03 | 0.01 | 0.01 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 4.26 | 28.79 | 13.72 | 10.72 | 9.32 |
| Tax Rate(%) | 35.13 | 26.63 | 29.33 | 26.41 | 26.13 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 0.85 | 1.41 | 0.36 | 0.80 | 13.42 |
| EBIT Margin(%) | 1.37 | 1.54 | 0.35 | 0.74 | 13.27 |
| Pre Tax Margin(%) | 1.25 | 1.45 | 0.30 | 0.73 | 12.97 |
| PAT Margin (%) | 0.81 | 1.06 | 0.21 | 0.53 | 9.58 |
| Cash Profit Margin (%) | 0.81 | 1.09 | 0.23 | 0.60 | 10.04 |
| Performance Ratios | |||||
| ROA(%) | 2.11 | 0.79 | 0.82 | 2.25 | 7.11 |
| ROE(%) | 122.76 | 70.92 | 24.51 | 13.33 | 8.62 |
| ROCE(%) | 99.51 | 102.54 | 18.16 | 7.39 | 11.16 |
| Asset Turnover(x) | 2.61 | 0.74 | 3.85 | 4.21 | 0.74 |
| Sales/Fixed Asset(x) | - | 1,909.86 | 1,621.56 | 339.30 | 11.83 |
| Working Capital/Sales(x) | 94.25 | 49.60 | 106.23 | 6.36 | 0.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | - | - | 0.08 |
| Receivable days | 49.35 | 84.61 | 31.70 | 51.05 | 103.36 |
| Inventory Days | 6.35 | 32.64 | 31.45 | 7.72 | 57.20 |
| Payable days | 36.33 | 77.15 | 54.31 | 50.25 | 80.60 |
| Valuation Parameters | |||||
| PER(x) | 33.42 | 1.75 | 46.26 | 32.97 | 28.98 |
| PCE(x) | 33.36 | 47.61 | 43.30 | 29.30 | 27.67 |
| Price/Book(x) | 25.46 | 25.62 | 10.10 | 4.11 | 2.39 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.28 | 0.48 | 0.10 | 0.28 | 2.58 |
| EV/Core EBITDA(x) | 20.80 | 30.47 | 26.52 | 35.05 | 18.83 |
| EV/EBIT(x) | 20.82 | 31.06 | 27.64 | 38.20 | 19.48 |
| EV/CE(x) | 11.42 | 23.51 | 9.81 | 1.78 | 2.01 |
| M Cap / Sales | 0.27 | 0.52 | 0.10 | 0.18 | 2.78 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 692.75 | 1.00 | 460.67 | 3,015.14 | 1,716.59 |
| Core EBITDA Growth(%) | 591.52 | 337.97 | 150.61 | 83.73 | 1,954.40 |
| EBIT Growth(%) | 604.09 | 347.82 | 162.10 | 74.33 | 1,886.53 |
| PAT Growth(%) | 503.20 | 403.44 | 124.31 | 73.47 | 3,362.50 |
| EPS Growth(%) | -78.46 | 403.44 | 124.31 | 73.47 | 3,365.97 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.34 | - | - | 2.72 | 0.11 |
| Current Ratio(x) | 1.02 | 1.01 | 1.02 | 1.59 | 7.38 |
| Quick Ratio(x) | 0.95 | 1.00 | 0.64 | 1.46 | 6.10 |
| Interest Cover(x) | 11.55 | 17.46 | 7.72 | 43.12 | 45.64 |
| Total Debt/Mcap(x) | 0.05 | - | - | 0.66 | 0.05 |
Compare Financial Ratios of peers of REMEDIUM LIFECARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| REMEDIUM LIFECARE | ₹216.5 Cr | -4.1% | -19.6% | -81% | Stock Analytics | |
| ADANI ENTERPRISES | ₹289,007.0 Cr | -0.1% | -13.8% | -13% | Stock Analytics | |
| REDINGTON | ₹16,389.9 Cr | 1.2% | 9.2% | 26.7% | Stock Analytics | |
| MMTC | ₹12,120.0 Cr | -3.7% | 3.5% | 38.5% | Stock Analytics | |
| HONASA CONSUMER | ₹8,138.5 Cr | -5.9% | -34.1% | -35% | Stock Analytics | |
| MSTC | ₹5,411.3 Cr | -1.5% | 26.9% | 78.4% | Stock Analytics | |
REMEDIUM LIFECARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| REMEDIUM LIFECARE | -4.1% |
-19.6% |
-81% |
| SENSEX | -0.6% |
2.3% |
16.9% |
You may also like the below Video Courses
